The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.

The Food and Drug Administration on Thursday approved Journavx, a non-opioid painkiller that is the first novel pain drug to win government authorization in more than 20 years. Vertex ...

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under the brand name Journavx.

Vertex Pharmaceuticals announced that Journavx will be priced at $15.50 per pill.The FDA-approved medication, available as a 50-milligram prescription tablet taken every 12 hours, offers a non ...

The FDA's approval process for Journavx included an evaluation of its safety and efficacy. Clinical trials demonstrated that the drug is effective in managing acute pain without the adverse ...

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under the brand name Journavx.

FDA approves Journavx, the first new painkiller in over two decades. The new drug will carry a list price of $15.50 per pill, making it many times more expensive than comparable opioids.

Among the patients who received Journavx in the clinical trials was a 50-year-old woman from the Atlanta area. She had a nose job in October 2023 and began taking the pill immediately afterward in ...

FDA approves Journavx, the first new painkiller in over two decades. The new drug will carry a list price of $15.50 per pill, making it many times more expensive than comparable opioids.

FDA approves Journavx, the first new painkiller in over two decades. The new drug will carry a list price of $15.50 per pill, making it many times more expensive than comparable opioids.

The new drug will carry a list price of $15.50 per pill, making it many times more expensive than comparable opioids.

FDA approves Journavx, the first new painkiller in over two decades. The new pain pill is designed to eliminate risks of addiction and overdose but it's more expensive than opioids and may be less ...